查看文章

Despite the advances in science, infectious diseases remain a major driver of morbidity and mortality worldwide. The recent outbreak of severe acute respiratory syndrome coronavirus (SARS-CoV-2) has questioned whether the current global health system can offer the needed protection against an array of infectious disease threats. Furthermore, it has re-ignited the urgency to develop and deploy countermeasures to control infectious diseases. To add to the above-established issues is the rapid emergence of antimicrobial resistance (AMR) infections. However, evidence is emerging that the field of nanotechnology is beginning to address all the challenges presented by diverse infectious pathogens. Nanotechnology approaches are increasingly and effectively being developed to design new therapeutic biomaterials, develop new vaccines and as drug delivery systems for the treatment of infectious diseases. This …